InvestorsHub Logo
Followers 828
Posts 119319
Boards Moderated 16
Alias Born 09/05/2002

Re: goombajhny post# 2549

Wednesday, 05/10/2017 12:35:13 PM

Wednesday, May 10, 2017 12:35:13 PM

Post# of 2795
One step at a time. OCRX has to get to phase-3, succeed in one or more phase-3 trials, and then submit an NDA. So, potential FDA approval is several years away.

Still, the valuation is so cheap that the share price could soar on positive news, such as FDA acceptance of a trial design for phase-3.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.